Sunshine Biopharma, Inc. - Bathi operasional EBITDA SBFM
Sunshine Biopharma (SBFM) combines the production of generics with the search for new oncology treatments to achieve self-financing. The EBITDA on the GURU.Markets chart clearly demonstrates the trend, where 0.00 records a new level. However, fierce competition in the pharmaceutical sector and a constant shortage of funds due to loss-making developments leave the company dependent on third-party investments.
Sunshine Biopharma - rincian analitis lan metrik utama (SBFM)
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Koefisien Total Utang marang Modal Sunshine Biopharma|SBFM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal sunshinebiopharma.com|SBFM - Utang perusahaan|Rasio utang marang nilai buku Sunshine Biopharma|SBFM - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Sunshine Biopharma|Rasio jangkoan perantara sunshinebiopharma.com
- statistik bathi lan rasio pasar:
SBFM - Bathi resik|Prakiraan bathi perusahaan Sunshine Biopharma|SBFM - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Sunshine Biopharma Inc.|SBFM - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Sunshine Biopharma|SBFM - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Sunshine Biopharma|SBFM - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sunshinebiopharma.com|SBFM - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Sunshine Biopharma
Analisis kabeh metrik perusahaan:Sunshine Biopharma Inc. - SBFM
This metric reflects the actual cash flow from core operations before depreciation and taxes, allowing investors to strip away one-time factors and assess the sustainability of operational efficiency. Analyzing absolute operating profit is critical for Sunshine Biopharma (SBFM), as future pricing power derived from intellectual property on anti-cancer drugs transforms current expenditures into large-scale monopoly profits.
Pesaing Sunshine Biopharma (SBFM)
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Personalis, Inc. (PSNL)|Pendapatan operasional sadurunge ngurangi amortisasi erasca.com|Delcath Systems - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Y-mAbs Therapeutics Inc YMAB|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CADL (Candel Therapeutics) - Bathi operasional sadurunge amortisasi|Accuray Incorporated (ARAY) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLS - Pendapatan operasional sadurunge ngurangi amortisasi|ACTU (Actuate Therapeutics) - Bathi operasional EBITDA|CTOR: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA HURA|Pendapatan operasional sadurunge ngurangi amortisasi Protara Tx|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Fate Therapeutics, Inc. FATE|WHWK: Bathi operasional sadurunge amortisasi|TScan - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Champions Oncology|XBIT (xbiotech.com) - Bathi operasional sadurunge ngurangi amortisasi|CEL-SCI - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|OSTX (OS Therapies Incorporated) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi RADX|Bathi operasional EBITDA ARTV|Pendapatan operasional sadurunge ngurangi amortisasi adlainortye.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Veru Pharma VERU|Tempest Therapeutics Corp (TPST) - Bathi sadurunge bunga, pajak, lan amortisasi|XLO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi RENB|MURA: Bathi operasional EBITDA|Kairos Pharma - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|OKUR (OnKure Therapeutics, Inc.) - Bathi operasional EBITDA|Bathi operasional EBITDA CytoMed|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Curis, Inc. (CRIS)|APLM (apollomicsinc.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tharimmune THAR|ADVB - Bathi operasional sadurunge ngurangi amortisasi|Genprex, Inc - Bathi operasional EBITDA|CLDI - Bathi operasional EBITDA|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLRX - Pendapatan operasional sadurunge ngurangi amortisasi|PPBT (Purple Biotech Ltd.) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi AONC|Bathi operasional EBITDA BGNE|CKPT: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|ICAD - Bathi operasional sadurunge ngurangi amortisasi|Ikena - Bathi operasional EBITDA|Notable Labs Ltd (NTBL) - Bathi operasional sadurunge ngurangi amortisasi|VIRX: Bathi operasional EBITDA|MorphoSys Corporation (MOR) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAYA Biosciences|Bathi operasional sadurunge amortisasi AAPGV (ascentage.com)
